Project Grant R01HL186276
- Federal Project Grant Award Summary The University of California, San Diego received a $1,519,594 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through May 31, 2029. The award supports fundamental research to advance understanding of biological mechanisms in the infarct borderzone—the critical region between dead and healthy heart tissue following myocardial infarction. This...
- Federal Grant Award Summary The University of California, San Diego received a $3,008,247 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for August 31, 2029. This research grant supports investigation of cell-type specific mechanisms underlying mitral valve prolapse (MVP), one of the most prevalent valvular heart diseases affecting 2-3% of the general...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,113,961 Project Grant to The Regents of the University of California, San Francisco on August 10, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support research investigating how centrioles direct mammalian development. The research focuses on understanding the molecular and cell biological mechanisms through which centriole defects contribute to congenital heart disease,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $231,552 Project Grant to the University of California, San Diego on September 16, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This research project, titled "Tissue Elasticity and Viscosity Modulates Macrophage-Fibroblast Signaling in Cardiac Fibrosis," focuses on investigating the mechanisms underlying cardiac fibrosis through the study of interactions between...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, San Diego a Project Grant totaling $1,072,936 under the Cardiovascular Diseases Research program (CFDA 93.837) with an award date of September 15, 2025, and a completion deadline of June 30, 2029. The grant funds research into protein aggregation mechanisms in hematopoietic stem cells (HSCs), with the primary deliverable being fundamental scientific discoveries...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of California, San Francisco a $556,295 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, with completion scheduled for May 31, 2030. This award supports research to advance understanding of cardiac pacemaking physiology and sinus node dysfunction (SND) through investigation of specialized pacemaker cell subpopulations. The...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1.507 million Project Grant to the University of California, San Diego to investigate the mechanisms controlling cardiac myosin heavy chain (MYH) gene regulation and isoform switching between MYH6 and MYH7 proteins. The research, funded under CFDA 93.837 (Cardiovascular Diseases Research), commenced August 1, 2025, and extends through May 31, 2029. The project employs a multidisciplinary approach to...
- Grant Award Summary The University of California, San Diego received a $799,256 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for March 31, 2031. The award funds basic research investigating cardiac protection through neuromodulation following myocardial infarction. The research employs an integrated cardiac-neuro-immune approach examining three key...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of California, Irvine a Project Grant of $711,796 under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2026 through April 30, 2030. The award funds development of a nanomaterial-engineered proteomic (NANOPRO) platform designed to map protein composition across distinct curved membrane structures in cardiomyocytes—specifically caveolae, clathrin-coated pits,...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded University of California, Berkeley $298,512 under the Cardiovascular Diseases Research program (CFDA 93.837) for a Project Grant effective August 1, 2025, through June 30, 2027. The award funds fundamental research investigating the role of Bone Morphogenetic Protein (BMP) signaling in cardiac neural crest (CDNC) development, which has direct implications for understanding congenital heart defects—the...
The University of California, San Diego received a $609,574 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 1, 2026, with a completion date of March 31, 2030. The grant funds basic research investigating the cellular and molecular mechanisms that regulate cardiac chamber morphology, specifically how cardiomyocytes acquire distinct shapes and organizational patterns in different regions of the developing ventricle. The research leverages zebrafish embryo models to identify genes and signaling pathways—including actomyosin dynamics, biomechanical forces, and TBX5A-regulated pathways—that control the divergent cellular characteristics of the outer and inner ventricular curvatures, ultimately advancing understanding of normal heart development and potentially informing prevention or treatment of congenital heart defects. The project deliverables include original scientific research documenting the cellular mechanisms driving curvature-specific cell shape changes, characterization of F-actin cytoskeletal dynamics in different ventricular regions, and identification of molecular regulators controlling outer and inner curvature cell divergence. Research outputs will contribute to the broader NHLBI portfolio of mechanistic investigations into cardiovascular disease pathogenesis and development, with findings disseminated through peer-reviewed publications and presentations to the scientific community.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $609.6k | 6/17/26 |